Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?

Chao, Tze-Fan, Liu, Chia-Jen, Wang, Kang-Ling, Lin, Yenn-Jiang, Chang, Shih-Lin, Lo, Li-Wei, Hu, Yu-Feng, Tuan, Ta-Chuan +3 more·2015·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2014.11.046

Cited by (257)

Items 101–200 of 257

  1. Stroke prevention in atrial fibrillation: State of the art
    Yan‐Guang Li, Gregory Y.H. Lip · 2018 · International Journal of Cardiology
  2. Risk and predictors of subsequent cancers of patients with newly-diagnosed atrial fibrillation — A nationwide population-based study
    Yi‐Ping Hung, Yu‐Wen Hu, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung et al. · 2019 · International Journal of Cardiology
  3. Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
    Christina Ji‐Young Lee, Anne Pernille Toft‐Petersen, Brice Ozenne, Matthew David Phelps, Jonas Bjerring Olesen, Patrick T. Ellinor, Gunnar Gislason, Gregory Y.H. Lip, Christian Tobias Torp-Pedersen, Thomas Alexander Gerds · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  4. Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score
    Jindong Chen, Mengmeng Zhou, Hao Wang, Zhihuang Zheng, Wenwen Rong, Ben He, Liang Zhao · 2021 · Journal of Thrombosis and Thrombolysis
  5. Stroke prevention in atrial fibrillation: comparison of recent international guidelines
    Tze‐Fan Chao, Milan A Nedeljkovic, Gregory Y.H. Lip, Tatjana Potpara · 2020 · European Heart Journal Supplements
  6. Recurrence after thoracoscopic surgery for spontaneous pneumothorax.
    Daisuke Matsuzoe, Akio Iwasaki, Kan Okabayashi, Takeshi Shiraishi, Kiyoshi INADA, S Yoneda, Y Yoshinaga, Y. Makimoto, Kenji Kawahara, T Shirakusa · 1999 · PubMed
  7. Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
    Po-Yin Chang, Wei‐Ting Wang, Yi‐Wen Tsai, Hao‐Min Cheng, Wei-Lun Wu, Hui‐Chin Chang, Chen‐Huan Chen, Shih‐Hwa Chiou, Gregory Y.H. Lip, Chern‐En Chiang · 2021 · Thrombosis and Haemostasis
  8. Atrial fibrillation as a new independent risk factor for thromboembolic events: hemodynamics and vascular consequence of long ventricular pauses
    Германова Ольга Андреевна, Giuseppe Galati, Andrey GERMANOV, Alexandros STEFANIDIS · 2022 · Minerva Cardiology and Angiology
  9. A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation
    Gregory Y.H. Lip, Tatjana Potpara, Giuseppe Boriani, Carina Blomström‐Lundqvist · 2016 · Journal of Internal Medicine
  10. CHA 2 DS 2 -VASc Recalibration With an Additional Age Category (50-64 Years) Enhances Stroke Risk Stratification in Chinese Patients With Atrial Fibrillation
    Pak‐Hei Chan, Chu‐Pak Lau, Hung‐Fat Tse, Chern‐En Chiang, Chung‐Wah Siu · 2016 · Canadian Journal of Cardiology
  11. Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation
    Maurizio Galderisi, Erwan Donal, Julien Magné, Francesco Lo Iudice, Eustachio Agricola, Leyla Elif Sade, Matteo Cameli, Ehud Schwammenthal, Nuno Miguel Cardim, Bernard Cosyns et al. · 2017 · European Heart Journal - Cardiovascular Imaging
  12. Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
    Li‐Kai Tsai, Huey-Juan Lin, Su‐Kiat Chua, Pen‐Chih Liao, Yuan Yang, Ping-Chen Chou, Chun‐Wei Lee, Mao-Jen Lin, Hsi-Ming Chen, Jung-Tze Yeh et al. · 2017 · Journal of Stroke and Cerebrovascular Diseases
  13. Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors
    Husam Mohamed Abdel-Qadir, Sheldon M. Singh, Andrea Pang, Peter C. Austin, Cynthia Anne Jackevicius, Karen Tu, Paul Dorian, Dennis T. Ko · 2021 · JAMA Cardiology
  14. Non‐vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years
    Chuan-Tsai Tsai, Jo‐Nan Liao, Su‐Jung Chen, Yu‐Ru Jiang, Tzeng‐Ji Chen, Tze‐Fan Chao · 2021 · European Journal of Clinical Investigation
  15. Predictive value of neutrophil to lymphocyte ratio for ischemic stroke in patients with atrial fibrillation: A meta-analysis
    M. Lu, Yeying Zhang, Rui Liu, Xiaoming He, Bo-Nan Hou · 2022 · Frontiers in Neurology
  16. Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
    Yun Gi Kim, Jong‐Il Choi, Ki Yung Boo, Do Young Kim, Yeji Hong, Min Sun Kim, Kwang‐No Lee, Jaemin Shim, Jin Seok Kim, Young‐Hoon Kim · 2019 · Clinical Cardiology
  17. Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: A nationwide cohort study
    Ting‐Yung Chang, Yi‐Hsin Chan, Chern‐En Chiang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung et al. · 2020 · Heart Rhythm
  18. CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban
    W. Frank Peacock, Sally G. Tamayo, Manesh R. Patel, Nicholas Sicignano, Kathleen Pillsbury Hopf, Žhong Yuan · 2016 · Annals of Emergency Medicine
  19. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor
    Tatjana Potpara, Nikolaos Dagres, Nebojša M. Mujović, Dragan Vasić, Milika Ašanin, Milan A Nedeljkovic, Francisco R. Marín, Laurent Fauchier, Carina Blomström‐Lundqvist, Gregory Y.H. Lip · 2016 · Advances in Therapy
  20. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events—A cohort study
    Song‐Yun Chu, Jie Jiang, Yuling Wang, Qin‐Hui Sheng, Jing Zhou, Yansheng Ding · 2019 · Heart & Lung
  21. Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA 2 DS 2 ‐VASc Scores: Findings From the ORBIT‐AF I and II Registries
    Larry R. Jackson, Sunghee Kim, Gregg C. Fonarow, James V. Freeman, Bernard John Gersh, Alan S. Go, Elaine M. Hylek, Peter Russell Kowey, Kenneth W. Mahaffey, Daniel E. Singer et al. · 2018 · Journal of the American Heart Association
  22. European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation
    Cheng-Hung Li, Chia‐Jen Liu, Annie Y. Chou, Tze‐Fan Chao, Ta‐Chuan Tuan, Su‐Jung Chen, Kang-Ling Wang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo et al. · 2016 · Scientific Reports
  23. Comparing Management and Outcomes in Men and Women With Nonvalvular Atrial Fibrillation
    Yoav Arnson, Moshe Hoshen, Adi Berliner Senderey, Orna Reges, Ran D. Balicer, Morton Leibowitz, Meytal Avgil Tsadok, Moti Haim · 2018 · JACC. Clinical electrophysiology
  24. Can echocardiography improve the prediction of thromboembolic risk in atrial fibrillation? Evidences and perspectives
    Antonella Tufano, Maurizio Galderisi · 2020 · Internal and Emergency Medicine
  25. Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation
    Rowlens M. Melduni, Bernard John Gersh, Waldemar E. Wysokiński, Naser M. Ammash, Paul A. Friedman, David O. Hodge, Krishnaswamy Chandrasekaran, Jae K. Oh, Hon-Chi Lee · 2018 · The American Journal of Cardiology
  26. Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Changsheng Ma, Shulin Wu, Shaowen Liu, Yaling Han · 2024 · 老年心脏病学杂志：英文版
  27. Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA 2 DS 2 -VASc Score 1 in Men, 2 in Women) Be Anticoagulated?
    John A. Savino, Jonathan L. Halperin · 2016 · Circulation
  28. Usefulness of the CHA2DS2-VASc Score to Predict the Risk of Sudden Cardiac Death and Ventricular Arrhythmias in Patients With Atrial Fibrillation
    Ling Kuo, Tze‐Fan Chao, Chia‐Jen Liu, Su‐Jung Chen, Ta‐Chuan Tuan, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Fa‐Po Chung et al. · 2018 · The American Journal of Cardiology
  29. Biomarkers of Atrial Fibrillation: Which One Is a True Marker?
    Pipin Ardhianto, Yoga Yuniadi · 2019 · Cardiology Research and Practice
  30. Thromboembolic risk stratification in atrial fibrillation—beyond clinical risk scores
    Darryl Wan, Jason G. Andrade, Zachary Laksman · 2021 · Reviews in Cardiovascular Medicine
  31. Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation
    Peter Brønnum Nielsen, Gregory Y.H. Lip · 2017 · Circulation
  32. Predictors of ischemic stroke for low-risk patients with atrial fibrillation: A matched case-control study
    Soonil Kwon, Tae Jung Kim, Eue‐Keun Choi, Hyo‐Jeong Ahn, Euijae Lee, So‐Ryoung Lee, Sang‐Bae Ko, Seil Oh, Gregory Y.H. Lip · 2021 · Heart Rhythm
  33. Office, central and ambulatory blood pressure for predicting incident atrial fibrillation in older adults
    Kenji Matsumoto, Zhezhen Jin, Shunichi Homma, Mitchell S.V. Elkind, Joseph E. Schwartz, Tatjana Rundek, Carlo M. Mannina, Kazato Ito, Ralph L. Sacco, Marco R. Di Tullio · 2020 · Journal of Hypertension
  34. Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation
    Laura Ueberham, Nikolaos Dagres, Tatjana Potpara, Andreas Bollmann, Gerhard Hindricks · 2017 · Advances in Therapy
  35. The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study
    Chuan-Tsai Tsai, Yi‐Hsin Chan, Jo‐Nan Liao, Tzeng‐Ji Chen, Gregory Y.H. Lip, Shih-Ann Chen, Tze‐Fan Chao · 2024 · BMC Medicine
  36. Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation
    Walid I. Saliba · 2015 · American Journal of Cardiovascular Drugs
  37. Regional function analysis of left atrial appendage using motion estimation CT and risk of stroke in patients with atrial fibrillation
    Abdullah Alissa, Yuko Y. Inoue, J. Cammin, Qiulin Tang, Saman Nazarian, Hugh G Calkins, Elliot K. Fishman, Katsuyuki Taguchi, Hiroshi Ashikaga · 2015 · European Heart Journal - Cardiovascular Imaging
  38. 2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
    Jung‐Myung Lee, Boyoung Joung, Myung‐Jin Cha, Ji Hyun Lee, Woo‐Hyun Lim, Tae‐Hoon Kim, Seung Yong Shin, Jae‐Sun Uhm, Hong Euy Lim, Jin‐Bae Kim et al. · 2018 · Korean Journal of Medicine
  39. Update and Unmet Needs on the Use of Nonvitamin K Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation
    Danilo Menichelli, Evaristo Ettorre, Arianna Pani, Francesco Violi, Pasquale Pignatelli, Daniele Pastori · 2019 · Current Problems in Cardiology
  40. Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation
    Gregory Y.H. Lip · 2015 · Expert Review of Cardiovascular Therapy
  41. Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: a cross-sectional study
    Kamila Kamili, Tingting Zheng, Chaodi Luo, Xuan Wang, Gang Tian · 2024 · Lipids in Health and Disease
  42. Anticoagulation in Chronic Kidney Disease
    Marco Montomoli, Boris Gonzales Candia, Adriana Acosta Barrios, Elisa Pérez-Bernat · 2024 · Drugs
  43. Misconceptions and Facts About Atrial Fibrillation
    Edgar Argulian, David Conen, Franz H. Messerli · 2015 · The American Journal of Medicine
  44. Short‐term anticoagulation after acute cardioversion of early‐onset atrial fibrillation
    Andrea Saglietto, Gaetano Maria De Ferrari, Fiorenzo Gaïta, Matteo Anselmino · 2020 · European Journal of Clinical Investigation
  45. Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Low Stroke Risk
    Khi Yung Fong, Yiong Huak Chan, Colin Yeo, Gregory Y.H. Lip, Vern Hsen Tan · 2023 · The American Journal of Cardiology
  46. Antiplatelet agents in uncertain clinical scenarios—a bleeding nightmare
    Sean Esmonde, Divyesh Sharma, Aaron J. Peace · 2018 · Cardiovascular Diagnosis and Therapy
  47. Left Atrial Appendage Morphology and Physiology: “The Missing Piece in the Puzzle”
    Jorge E. Romero, Andrea Natale, Luigi Di Biase · 2015 · Journal of Cardiovascular Electrophysiology
  48. Atrial Fibrillation and Stroke
    Marco Proietti, Gregory Y.H. Lip · 2016 · Cardiology Clinics
  49. Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study
    Žhong Yuan, Erica A. Voss, Frank DeFalco, Guohua Pan, Patrick B. Ryan, Daniel Yannicelli, Christopher C. Nessel · 2017 · Journal of Stroke and Cerebrovascular Diseases
  50. The Application and Future of Big Database Studies in Cardiology: A Single-Center Experience.
    Kuang‐Tso Lee, Ai Ling Hour, Ben‐Chang Shia, Pao Hsien Chu · 2017 · Europe PMC (PubMed Central)
  51. Prevalence and risk factors of left atrial thrombus in patients with atrial fibrillation and lower class (IIa) recommendation to anticoagulants
    Beata Uziębło‐Życzkowska, Paweł Krzesiński, Agnieszka Jurek, Monika Budnik, Iwona Gorczyca−Michta, Agnieszka Kapłon‐Cieślicka, Marek Kiliszek, Agnieszka Wójcik, Monika M. Gawalko, Olga Elżbieta Jelonek et al. · 2020 · Cardiovascular Diagnosis and Therapy
  52. Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
    Ling Kuo, Yi‐Hsin Chan, Jo‐Nan Liao, Shih‐Ann Chen, Tze‐Fan Chao · 2021 · Korean Circulation Journal
  53. Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal
    Antoni Martínez‐Rubio, Mario DiazNuila Alcazar, Anna Soria Cadena, Roger Martínez-Torrecilla · 2016 · European Cardiology Review
  54. How do aging and comorbidities impact risk of ischemic stroke in patients with atrial fibrillation
    Jo‐Nan Liao, Tze‐Fan Chao, Shih‐Ann Chen · 2018 · Trends in Cardiovascular Medicine
  55. 2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
    Jung‐Myung Lee, Boyoung Joung, Myung‐Jin Cha, Ji Hyun Lee, Woo‐Hyun Lim, Tae‐Hoon Kim, Seung Yong Shin, Jae‐Sun Uhm, Hong Euy Lim, Jin‐Bae Kim et al. · 2018 · Korean Journal of Medicine
  56. Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients
    Tommy Andersson, Anders Magnuson, Ing‐Liss Bryngelsson, Ole Fröbert, Karin Maria Henriksson, Nils G. Edvardsson, Dritan Poçi · 2017 · PLoS ONE
  57. Should Every Patient With Atrial Fibrillation and a CHA2DS2-VASc Score of 1 Be Anticoagulated? A Systematic Review of 37,030 Patients
    Jolien Neefs, Thomas A. Klamer, Sébastien P.J. Krul, Joris R. de Groot · 2019 · Cardiology in Review
  58. Stroke prevention in patients with atrial flutter: many questions still unanswered
    Tze‐Fan Chao, Laurent Fauchier · 2018 · EP Europace
  59. How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring
    Gregory Y.H. Lip · 2016 · Circulation
  60. 2018 KHRS Expert Consensus Recommendation for Oral Anticoagulants Choice and Appropriate Doses: Specific Situation and High Risk Patients
    Ki Hong Lee, Boyoung Joung, So‐Ryoung Lee, You Mi Hwang, Junbeom Park, Yong‐Soo Baek, Yae Min Park, Jin‐Kyu Park, Hwan Cheol Park, Hyung Wook Park et al. · 2018 · Korean Journal of Medicine
  61. Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)
    Xiufeng Xie, TianChang Li · 2020 · Acta cardiologica. Supplementum
  62. Mobile health technology integrated care in atrial fibrillation patients with diabetes mellitus in China: A subgroup analysis of the mAFA‐II cluster randomized clinical trial
    Yutao Guo, Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Hui Zhang, Gregory Y.H. Lip, the mAF‐App II Trial Investigators · 2023 · European Journal of Clinical Investigation
  63. Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation
    Simona Minardi, Luigi Sciarra, Antonio Gianluca Robles, Antonio Scarà, Francesco Sciarra, Gabriele De Masi De Luca, Silvio Romano · 2024 · Frontiers in Pharmacology
  64. Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
    Marco Alings · 2016 · Arrhythmia & Electrophysiology Review
  65. Relation of Electrocardiographic Left Atrial Abnormalities to Risk of Stroke in Patients with Atrial Fibrillation
    Yuko Y. Inoue, Esra Gücük İpek, Irfan M. Khurram, Luisa Ciuffo, Jonathan Chrispin, Stefan Loy Zimmerman, Joseph Edward Marine, John Rickard, DAVID D. SPRAGG, Saman Nazarian et al. · 2018 · The American Journal of Cardiology
  66. The continuous challenge of antithrombotic strategies in diabetes: focus on direct oral anticoagulants
    Fulvio Pomero, Francesco Dentali, Nicola Mumoli, Pietro Salomone, Flavio Tangianu, Giovambattista Desideri, Daniela Mastroiacovo · 2019 · Acta Diabetologica
  67. Atrial fibrillation and hypertension: current understanding of the pathogenesis, diagnosis, and treatment
    M. A. Kirgizova, Roman Efimovich Batalov, B. A. Tatarsky, Sergey Valentinovich Popov · 2019 · Сибирский журнал клинической и экспериментальной медицины
  68. Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom?
    Panteleimon Ε. Papakonstantinou, Konstantinos P Tsioufis · 2023 · Journal of Cardiovascular Pharmacology
  69. Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation
    Annie Y. Chou, Chia‐Jen Liu, Tze‐Fan Chao, Kang-Ling Wang, Ta‐Chuan Tuan, Tzeng‐Ji Chen, Shih‐Ann Chen · 2016 · Medicine
  70. Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
    Chinese Society of Cardiology, Chinese Medical Association, Heart Rhythm Committee of Chinese Society of Biomedical Engineering · 2024 · Cardiology Discovery
  71. Stroke Risk Stratification in Patients With Atrial Fibrillation
    A. John Camm, Irene Savelieva · 2015 · Journal of the American College of Cardiology
  72. Ischemic stroke risk in East Asian patients with CHA2DS2-VASc score of 1: systematic review and meta-analysis
    Ying Bai, Alena Shantsila, Gregory Y.H. Lip · 2017 · Expert Review of Cardiovascular Therapy
  73. Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation
    Michael Ghannam, Aman Chugh · 2017 · Heart
  74. Short lookback periods causing exaggerated stroke risk estimates in atrial fibrillation may expose patients to unnecessary anticoagulant treatment
    Leif Friberg · 2019 · Pharmacoepidemiology and Drug Safety
  75. Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
    Anna Michalska, Iwona Gorczyca−Michta, Magdalena Chrapek, Agnieszka Kapłon‐Cieślicka, Beata Uziębło‐Życzkowska, Katarzyna Starzyk, Olga Elżbieta Jelonek, Monika Budnik, Monika M. Gawalko, Paweł Krzesiński et al. · 2020 · Medicine
  76. Sex-Related Differences in Left Atrial Low-Voltage Areas According to CHA2DS2-VA Scores among Patients with Atrial Fibrillation
    Do Young Kim, Yun Gi Kim, Ha Young Choi, Yun Young Choi, Ki Yung Boo, Kwang‐No Lee, Seung‐Young Roh, Jaemin Shim, Jong‐Il Choi, Young‐Hoon Kim · 2022 · Journal of Clinical Medicine
  77. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients
    Gregory Y.H. Lip, Tereza Lanitis, Jack Mardekian, Thitima Kongnakorn, Hemant M. Phatak, Paul Dorian · 2015 · Stroke
  78. Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors
    Sun Young Choi, Moo Hyun Kim, Kwang Min Lee, Young–Rak Cho, Jong Sung Park, Seong Woo Kim, Jin Kyung Kim, Matthew Chung, Sung‐Cheol Yun, Gregory Y.H. Lip · 2020 · Journal of the American Heart Association
  79. Predictive value of bleeding risk scores in elderly patients with atrial fibrillation and oral anticoagulation
    Pablo Domínguez Erquicia, Sergio Raposeiras‐Roubín, Emad Abu‐Assi, Andrea Lizancos Castro, José Antonio Parada Barcía, André González-García, Ana Ledo Piñeiro, Vanesa Noriega Caro, Carla Iglesias Otero, Andrés Íñiguez · 2023 · 老年心脏病学杂志：英文版
  80. Patients with atrial fibrillation and CHA2DS2-VASc score 1: “To anticoagulate or not to anticoagulate? That is the question!”
    Giuseppe Patti, Ilaria Cavallari · 2015 · Heart Rhythm
  81. Recommendations on stroke prevention for patients having a CHA2DS2-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines
    Tze‐Fan Chao, Shih‐Ann Chen, Gregory Y.H. Lip · 2019 · Trends in Cardiovascular Medicine
  82. The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore
    Brigitte Woo, Toon Wei Lim, Wilson Tam · 2018 · Heart Lung and Circulation
  83. Impact of a single non-sex-related stroke risk factor on atrial fibrillation and oral anticoagulant outcomes: a systematic review and meta-analysis
    Maxim Grymonprez, Stéphane Steurbaut, An De Sutter, Lies Lahousse · 2020 · Open Heart
  84. Chronic Osteomyelitis Is Associated With Increased Risk of New-Onset Atrial Fibrillation: Evidence From a Nationwide Cohort of 23 Million People
    Lien‐Cheng Hsiao, Chih‐Hsin Muo, Che‐Yi Chou, Chun‐Hung Tseng, Ming-Fong Chen, Kuan‐Cheng Chang · 2016 · Canadian Journal of Cardiology
  85. Data Strengthen to Support Recommending Anticoagulant Therapy for All Atrial Fibrillation Patients With a CHA2DS2-VASc Score ≥1∗
    Hugh G Calkins · 2015 · Journal of the American College of Cardiology
  86. Investigation of Stroke Risk Factors and Prognostic Indicators in NVAF Patients with Low CHA2DS2-VASc Scores
    Tang-Gang Gao, Feng Gao, Weibin Huang, Jiayi Cai, Huili Yang, Chen-Chun Xiong, Yang Ruan, Sui-Feng Liu · 2023 · International Heart Journal
  87. Treatment with oral anticoagulant drugs restrained from patients with atrial fibrillation: An assessment in a geographically well-defined catchment area
    Per Andersson, Magnus Löndahl · 2016 · European Journal of Preventive Cardiology
  88. Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes
    Patrícia O. Guimarães, Eric David Peterson, Susanna R. Stevens, Yuliya V. Lokhnygina, Jennifer B. Green, Darren K. McGuire, Rury R. Holman, Renato D. Lópes · 2019 · International Journal of Cardiology
  89. Clinical decisions for appropriate management of patients with atrial fibrillation
    Giuseppe Boriani, Niccolò Bonini, Jacopo Francesco Imberti, Marco Vitolo, Luigi Gerra, Marta Mantovani, Kevin Serafini, Chiara Birtolo, Enrico Tartaglia, Davide Antonio Mei · 2024 · Panminerva Medica
  90. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia
    Graeme Wertheimer, Lre Bereznicki · 2018 · Journal of Cardiovascular Pharmacology and Therapeutics
  91. Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case
    Guowei Li, Lehana Thabane, Thomas Delate, Daniel M. Witt, Mitchell Levine, Ji Cheng, Anne Marie Holbrook · 2016 · PLoS ONE
  92. Factors determining elective cardioversion preceded with transesophageal echocardiography: two cardiology centres’ experiences
    Beata Uziębło‐Życzkowska, Marek Kiliszek, Iwona Gorczyca−Michta, Agnieszka Woronowicz-Chróściel, Bernadetta Bielecka, Paweł Wałek, Olga Elżbieta Jelonek, Beata Wożakowska−Kapłon, Paweł Krzesiński · 2020 · Polskie Archiwum Medycyny Wewnętrznej
  93. Management of Anticoagulant Therapy in Athletes and Sportspeople: Italian Federation of Centers for Diagnosis and Surveillance of the Antithrombotic Therapies (FCSA) Position Paper
    Elena Campello, Chiara Cappugi, Filippo Catalani, Daniela Poli, Paolo Bucciarelli · 2025 · Thrombosis and Haemostasis
  94. Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
    Daehoon Kim, Young Soo Lee, Jaemin Shim, Hee Tae Yu, Junbeom Park, Jin-Kyu Park, Il‐Young Oh, Ki-Woon Kang, Eue‐Keun Choi, Kyoung-Min Park et al. · 2026 · New England Journal of Medicine
  95. Atrial fibrillation and CHA2DS2VASc score of 1 - is there a problem in clinical practice?
    Е. И. Баранова, V. А. Pavlova, В. А. Ионин, E. Yu. Petrischeva, O. I. Bliznuk, Ekaterina Leonidovna Zaslavskaya, Yi Ma, D. S. Skuridin, E. V. Shlakhto · 2020 · Russian Journal of Cardiology
  96. Patients with atrial fibrillation and low risk of stroke: do they really need anticoagulation?
    Maria Trusz‐Gluza, Artur Filipecki, Dagmara Urbańczyk-Świć · 2015 · Polskie Archiwum Medycyny Wewnętrznej
  97. Selección de temas de actualidad en arritmias y estimulación cardiaca 2015
    Rafaél Peinado, Francisco Ruiz‐Mateas, Maite Izquierdo, Eduardo Arana‐Rueda, M. J. López Robledo, Miguel Angel Arias, Juan Jiménez‐Jáimez, Moisés Rodríguez‐Mañero, Javier Chimeno · 2016 · Revista Española de Cardiología
  98. Ischemic Stroke in Non-Gender-Related CHA2DS2-VA Score 0~1 Is Associated With H2FPEF Score Among the Patients With Atrial Fibrillation
    Min Hyeong Kim, Hee Tae Yu, Tae‐Hoon Kim, Dae In Lee, Jae‐Sun Uhm, Young Dae Kim, Hyo Suk Nam, Boyoung Joung, Moon‐Hyoung Lee, Ji Hoe Heo et al. · 2022 · Frontiers in Cardiovascular Medicine
  99. Prevention of cardiovascular outcomes in diabetic patients with atrial fibrillation: direct oral anticoagulants or warfarin?
    2019 · Clinical pharmacology and therapy
  100. Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
    Bernadetta Bielecka, Iwona Gorczyca−Michta, Agnieszka Ciba-Stemplewska, Beata Wożakowska−Kapłon · 2023 · International Journal of Environmental Research and Public Health